Recent Articles from MarketBeat
MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Website: https://www.marketbeat.com
Energy Recovery (NASDAQ:ERII) said it remains focused on executing its growth initiatives, managing costs and advancing its manufacturing footprint while geopolitical uncertainty continues to delay the timing of major desalination projects in the Middle East.
During the company’s second-quarter 202
Via MarketBeat · August 5, 2026
EverCommerce (NASDAQ:EVCM) reported second-quarter revenue that grew 2.7% year over year to $152 million, while adjusted EBITDA of $44.5 million exceeded the company’s guidance range. The company maintained its full-year outlook but said results are now expected to trend toward the lower end of its
Via MarketBeat · August 5, 2026
Duolingo (NASDAQ:DUOL) reported accelerating user growth in the second quarter, with daily active users rising 23% year over year, as the language-learning company continued to prioritize product improvements, retention and long-term audience expansion.
Co-founder and CEO Luis von Ahn said the comp
Via MarketBeat · August 5, 2026
eBay (NASDAQ:EBAY) reported second-quarter results that exceeded its guidance ranges and consensus expectations, driven by growth in focused categories, consumer-to-consumer sales, recommerce and newer initiatives including eBay Live, vehicles and shipping.
Gross merchandise volume, or GMV, increas
Via MarketBeat · August 5, 2026
Encore Capital Group (NASDAQ:ECPG) reported higher second-quarter earnings, record U.S. portfolio purchases and record global collections, while raising its 2026 outlook for collections and earnings per share.
Chief Executive Officer Ashish Masih said the company’s second-quarter global portfolio p
Via MarketBeat · August 5, 2026
Evolus (NASDAQ:EOLS) reported second-quarter revenue growth of 21% and raised the lower end of its full-year 2026 revenue outlook, citing market-share gains in neurotoxins and hyaluronic acid injectable gels, continued customer adoption of its portfolio and expanding international operations.
Globa
Via MarketBeat · August 5, 2026
Amdocs (NASDAQ:DOX) reported fiscal third-quarter 2026 revenue of approximately $1.175 billion, up 2.7% from a year earlier on a reported basis and 2.2% in constant currency. Non-GAAP diluted earnings per share totaled $1.84, in line with the midpoint of the company’s guidance.
President and CEO Sh
Via MarketBeat · August 5, 2026
Dave (NASDAQ:DAVE) reported second-quarter results marked by 30% revenue growth, expanding profitability and increased investment in customer acquisition, while raising its full-year outlook.
Revenue for the quarter ended June 30 rose 30% year over year to $171 million. Adjusted EBITDA increased 48
Via MarketBeat · August 5, 2026
Digi International (NASDAQ:DGII) reported record fiscal third-quarter 2026 revenue, annual recurring revenue, adjusted EBITDA margin and operating cash flow, while raising its outlook for the fourth quarter and full fiscal year.
Chief Financial Officer Jamie Loch said quarterly revenue reached $139
Via MarketBeat · August 5, 2026
Diodes (NASDAQ:DIOD) reported second-quarter revenue growth of 22% from a year earlier and issued third-quarter guidance that calls for continued expansion in sales, gross margin and adjusted earnings, citing demand across automotive, industrial and AI-related applications.
Revenue for the quarter
Via MarketBeat · August 5, 2026
Cytek Biosciences (NASDAQ:CTKB) reported second-quarter 2026 revenue growth of 6% year over year, supported by double-digit gains in the United States and China, while continued weakness in Europe and parts of Asia-Pacific limited overall growth.
Revenue for the quarter ended June 30 was $48.1 mill
Via MarketBeat · August 5, 2026
DoorDash (NASDAQ:DASH) executives said the company’s Q2 2026 performance reflected continued growth in restaurant delivery, grocery and retail, international operations and subscription adoption, while improved unit economics supported profitability and ongoing investment in technology.
During the
Via MarketBeat · August 5, 2026
Chime Financial (NASDAQ:CHYM) reported second-quarter results that showed accelerating member, revenue and transaction-profit growth, while the company raised its full-year outlook and outlined new product initiatives aimed at higher-income consumers.
Active members grew 20% year over year to 10.4
Via MarketBeat · August 5, 2026
Clearfield (NASDAQ:CLFD) reported fiscal third-quarter 2026 net sales of $43.9 million, up 13% from $38.8 million a year earlier and 28% sequentially, as the company advanced its push into data center connectivity while confronting continued delays in broadband-network deployment.
Net income from c
Via MarketBeat · August 5, 2026
Clover Health Investments (NASDAQ:CLOV) reported second-quarter results that showed continued Medicare Advantage membership growth alongside profitability, while raising its full-year 2026 outlook across its key financial measures.
Chief Executive Officer Andrew Toy said the company views its Clove
Via MarketBeat · August 5, 2026
Cirrus Logic (NASDAQ:CRUS) reported record fiscal first-quarter revenue of $460 million for the June quarter, up 2% sequentially and 13% from a year earlier, driven by higher component sales into smartphones. The company posted GAAP earnings per share of $1.47 and non-GAAP earnings per share of $1.8
Via MarketBeat · August 5, 2026
Central Garden & Pet (NASDAQ:CENT) reported an 8% decline in fiscal third-quarter net sales to $882 million, primarily reflecting its exit from the pet distribution business at the beginning of the quarter. Excluding that business, organic net sales rose 2% to $862 million, supported by growth in bo
Via MarketBeat · August 5, 2026
Coherus Oncology (NASDAQ:CHRS) said it is approaching several clinical data disclosures in the second half of 2026, while reporting continued growth for its LOQTORZI treatment and lower operating expenses following the divestiture of its UDENYCA franchise.
Chief Executive Officer Denny Lanfear said
Via MarketBeat · August 5, 2026
Carlsmed (NASDAQ:CARL) reported second-quarter 2026 revenue of $18.9 million, up 57% from $12.1 million a year earlier, as growth in its aprevo lumbar platform and contributions from its newer cervical offering lifted procedure volumes.
Chairman and Chief Executive Officer Mike Cordonnier said the
Via MarketBeat · August 5, 2026
Bumble (NASDAQ:BMBL) reported second-quarter results that were in line with its expectations, with revenue landing in the upper half of its guidance range and adjusted EBITDA exceeding the high end, as the dating-app company continued a technology and product transformation.
Founder and CEO Whitney
Via MarketBeat · August 5, 2026
biote (NASDAQ:BTMD) reported lower second-quarter revenue and a net loss as a voluntary recall of certain hormone pellets supplied by Asteria Health disrupted procedure volumes, while management said supply conditions have since normalized and should support sequential improvement in the second half
Via MarketBeat · August 5, 2026
Beyond Meat (NASDAQ:BYND) reported second-quarter 2026 revenue above its guidance range as international retail growth partially offset continued weakness in U.S. channels and international food service. Management said the company is pursuing a turnaround centered on expanding in Europe and Canada,
Via MarketBeat · August 5, 2026
Caris Life Sciences (NASDAQ:CAI) reported record clinical volume and raised its full-year revenue outlook after second-quarter revenue increased 45% from a year earlier, driven by growth in molecular profiling services, higher average selling prices and an expanding commercial organization.
The com
Via MarketBeat · August 5, 2026
Netlist (OTCMKTS:NLST) announced a five-year strategic alliance with Samsung covering a patent portfolio cross-license, memory product supply, technology cooperation and Samsung’s purchase of Netlist shares.
Chief Executive Officer Chuck Hong said the agreement represents a major milestone for Netl
Via MarketBeat · August 5, 2026
Axon Enterprise (NASDAQ:AXON) reported second-quarter revenue of $904 million, up 35% from a year earlier, as growth across software, connected devices and counter-drone offerings extended the company’s streak of quarterly revenue growth above 30% to 10 consecutive quarters.
During the company’s ea
Via MarketBeat · August 5, 2026
Biodesix (NASDAQ:BDSX) reported second-quarter 2026 revenue growth of 34% year over year, supported by increased diagnostic test volumes, higher average revenue per test and continued expansion of its commercial organization.
Total revenue was $26.9 million for the quarter, while diagnostic testing
Via MarketBeat · August 5, 2026
Blue Bird (NASDAQ:BLBD) reported fiscal 2026 third-quarter revenue of $517 million and adjusted EBITDA of $71 million, as the school-bus manufacturer said it exceeded its guidance across metrics and raised its full-year adjusted EBITDA outlook.
The company also announced an expanded collaboration w
Via MarketBeat · August 5, 2026
Billiontoone (NASDAQ:BLLN) reported second-quarter 2026 revenue growth of 64% year over year, driven by higher testing volumes and average selling prices across its prenatal and oncology businesses. The molecular diagnostics company also posted positive operating income and free cash flow while reit
Via MarketBeat · August 5, 2026
Amplitude (NASDAQ:AMPL) reported second-quarter 2026 revenue of $100.9 million, up 21% from a year earlier and 8% sequentially, as the product analytics company highlighted growth in enterprise customers, adoption of AI tools and the contribution from its Statsig acquisition.
Total annual recurring
Via MarketBeat · August 5, 2026
Alto Ingredients (NASDAQ:ALTO) reported a fourth consecutive quarter of positive gross profit, operating income, net income and adjusted EBITDA in the second quarter of 2026, citing stronger ethanol market conditions, improved essential ingredient pricing and contributions from federal 45Z tax credi
Via MarketBeat · August 5, 2026
AppLovin (NASDAQ:APP) reported second-quarter revenue of $1.92 billion, up 53% from a year earlier and 4% sequentially, while adjusted EBITDA rose 58% year-over-year to $1.61 billion. The company said both figures came in below its own guidance expectations, attributing the shortfall primarily to a
Via MarketBeat · August 5, 2026
Arcutis Biotherapeutics (NASDAQ:ARQT) reported second-quarter 2026 net product revenue of $129.9 million, up 59% from the prior-year period and 23% sequentially, as demand for its ZORYVE topical treatments continued to rise across approved dermatology indications.
The company generated net income o
Via MarketBeat · August 5, 2026
Amtech Systems (NASDAQ:ASYS) reported fiscal 2026 third-quarter revenue of $22.4 million, up 14% from the prior-year period and at the top end of its guidance range, as demand for artificial intelligence-related equipment supported growth in its Thermal Processing Solutions business.
Chairman and C
Via MarketBeat · August 5, 2026
Barrett Business Services (NASDAQ:BBSI) reported second-quarter growth in gross billings and worksite employees, though management said persistent economic uncertainty continued to weigh on hiring among existing clients.
Gross billings increased 2.6% year over year to $2.29 billion for the quarter
Via MarketBeat · August 5, 2026
ADMA Biologics (NASDAQ:ADMA) reported second-quarter revenue growth of 2% as increased sales of its ASCENIV immune globulin product offset pressure on BIVIGAM in the standard immunoglobulin market. The company reiterated its full-year financial outlook and said it remains on track to meet or exceed
Via MarketBeat · August 5, 2026
Airgain (NASDAQ:AIRG) reported second-quarter revenue of $13.7 million, up 19% sequentially and 0.7% from a year earlier, as growth in enterprise, automotive and consumer markets helped the wireless connectivity provider post positive adjusted EBITDA.
President and CEO Jacob Suen said the company e
Via MarketBeat · August 5, 2026
Akebia Therapeutics (NASDAQ:AKBA) reported second-quarter revenue growth for its Vafseo anemia treatment while highlighting an interim clinical result from the VOICE study and progress across its kidney disease pipeline.
Vafseo net product revenue reached $21.3 million in the second quarter of 2026
Via MarketBeat · August 5, 2026
AbCellera Biologics (NASDAQ:ABCL) said it expects to report top-line data “very soon” from its Phase I study of ABCL635, an antibody being evaluated for moderate-to-severe vasomotor symptoms, or hot flashes, associated with menopause.
President and Chief Executive Officer Dr. Carl Hansen said enrol
Via MarketBeat · August 5, 2026
American Coastal Insurance (NASDAQ:ACIC) reported second-quarter net income of $21.9 million as the Florida commercial residential property insurer navigated lower pricing and catastrophe losses while maintaining what management described as disciplined underwriting.
President and CEO Bennett Bradf
Via MarketBeat · August 5, 2026
Banco Santander Chile (NYSE:BSAC) reported second-quarter net income attributable to shareholders of more than CLP 382.6 billion, up 40% from both the prior quarter and a year earlier, as elevated inflation supported readjustment income and the bank maintained cost and risk discipline.
The lender g
Via MarketBeat · August 5, 2026
BrightView (NYSE:BV) reported third-quarter 2026 revenue growth led by its land maintenance business, while elevated fuel costs and a non-routine self-insurance adjustment weighed on profitability.
Total revenue increased 1.3% year over year to $718 million. Land maintenance revenue rose 2.3%, mark
Via MarketBeat · August 5, 2026
BlueLinx (NYSE:BXC) reported higher second-quarter sales, earnings and free cash flow as the building-products distributor cited share gains and improved pricing despite continued weakness in housing construction and repair-and-remodel activity.
Net sales increased more than 4% year over year to $8
Via MarketBeat · August 5, 2026
Chemours (NYSE:CC) said its second-quarter results reflected pricing gains, operational improvements and continued execution under its Pathway to Thrive strategy, while softer residential air-conditioning aftermarket demand weighed on sales in its Thermal & Specialized Solutions business.
Presi
Via MarketBeat · August 5, 2026
Ardent Health (NYSE:ARDT) reported second-quarter revenue of $1.62 billion and adjusted EBITDA of $115 million, as management said cost controls, a favorable payer contract renewal and strong cash flow helped offset weaker-than-expected volumes.
Surgeries and admissions were pressured during April
Via MarketBeat · August 5, 2026
Archrock (NYSE:AROC) reported second-quarter 2026 results marked by high contract-operations utilization, strong margins and continued free-cash-flow generation, while narrowing its full-year adjusted EBITDA outlook to account for near-term cost pressures and customer maintenance deferrals.
The com
Via MarketBeat · August 5, 2026
Brookfield Asset Management (NYSE:BAM) reported second-quarter fee-related earnings of $808 million, or $0.50 per share, up 20% from a year earlier, as the alternative asset manager posted its strongest fundraising quarter on record and highlighted growing activity in AI infrastructure, credit and r
Via MarketBeat · August 5, 2026
Brink's (NYSE:BCO) reported second-quarter results marked by 4% organic revenue growth, a 14% increase in ATM Managed Services and Digital Retail Solutions revenue, and record second-quarter operating and EBITDA margins, while raising its full-year profit expectations.
Chief Executive Officer Mark
Via MarketBeat · August 5, 2026
Amprius Technologies (NYSE:AMPX) reported record second-quarter revenue and raised its 2026 outlook for the second consecutive quarter, citing demand for its silicon-anode lithium-ion batteries in military and commercial drones, electric mobility and other emerging applications.
Revenue for the sec
Via MarketBeat · August 5, 2026
Angel Studios (NYSE:ANGX) reported second-quarter 2026 revenue growth of 28% as its Guild membership business expanded, while management said it remained committed to limiting its full-year adjusted EBITDA loss to no more than $25 million.
Total revenue reached $111 million in the quarter, up from
Via MarketBeat · August 5, 2026
SpaceX posted strong quarterly revenue growth, but cash burn, a rich valuation, upcoming insider lockup expirations, and S&P 500 exclusion pose risks that could outweigh near-term upside for SPCX stock.
Via MarketBeat · August 5, 2026
ContextLogic announced plans to acquire Gaylord Chemical Company, known as gChem, for $850 million in a cash transaction, marking the company’s second operating-business acquisition following its purchase of US Salt.
Chairman Raja Bobbili said the deal advances ContextLogic’s strategy of assembling
Via MarketBeat · August 5, 2026
Assurant (NYSE:AIZ) reported a second consecutive quarter of record earnings in the second quarter of 2026, supported by growth in its Global Lifestyle and Global Housing businesses. Management raised its full-year outlook, citing program expansion, improving operating performance and continued capi
Via MarketBeat · August 5, 2026
XPEL (NASDAQ:XPEL) reported record second-quarter revenue as growth in the United States, China and other Asia-Pacific markets offset continued pressure in dealerships, softer European results and a decline in India and Middle East revenue tied partly to vehicle availability.
Revenue increased 14.7
Via MarketBeat · August 5, 2026
Adient (NYSE:ADNT) reported third-quarter fiscal 2026 revenue of approximately $3.9 billion, up 5% from a year earlier, while adjusted EBITDA was flat at $225 million as conflict-related commodity and freight costs, customer production disruptions and operating inefficiencies weighed on profitabilit
Via MarketBeat · August 5, 2026
American Financial Group (NYSE:AFG) reported record second-quarter pre-tax property and casualty operating income, supported by stronger underwriting margins, premium growth and higher investment income.
The insurer posted core net operating earnings of $2.82 per share for the second quarter of 202
Via MarketBeat · August 5, 2026
Urogen Pharma (NASDAQ:URGN) reported second-quarter 2026 revenue of $72.5 million, up from $24.2 million a year earlier, as the commercial launch of bladder cancer treatment ZUSDURI continued to gain traction. The company recorded a net loss of $14.4 million, or $0.28 per share, compared with a $49.
Via MarketBeat · August 5, 2026
United Therapeutics (NASDAQ:UTHR) reported second-quarter 2026 revenue of approximately $783 million, essentially flat from the first quarter, as competitive pressure affected sales of its nebulized TYVASO therapy. Company executives said they expect stronger performance in the second half of the ye
Via MarketBeat · August 5, 2026
Weyco Group (NASDAQ:WEYS) reported higher second-quarter sales and sharply increased earnings, with results substantially supported by tariff refunds following the invalidation of certain import duties by the U.S. Supreme Court.
Net sales for the second quarter of 2026 rose 7% year over year to $62
Via MarketBeat · August 5, 2026
TeraWulf (NASDAQ:WULF) said its second-quarter results reflected growing high-performance computing, or HPC, lease revenue as additional capacity came online at its Lake Mariner campus, alongside a broader expansion strategy that includes a major Anthropic lease in Kentucky, the acquisition of the M
Via MarketBeat · August 5, 2026
Trinity Capital (NASDAQ:TRIN) reported record second-quarter originations and growth in net asset value, while management said its expanding managed-funds platform, recent equipment-finance acquisition and joint ventures are intended to support earnings growth over time.
Net investment income total
Via MarketBeat · August 5, 2026
Trivago N.V. ADS (NASDAQ:TRVG) reported second-quarter revenue growth of 21% and positive adjusted EBITDA, extending its streak of double-digit quarterly revenue growth to six consecutive quarters as the travel-search company raised its full-year outlook.
Total revenue reached EUR 168.4 million in
Via MarketBeat · August 5, 2026
Thomson Reuters (NASDAQ:TRI) reported second-quarter 2026 organic revenue growth of 8%, led by accelerating performance across its Legal, Corporates, and Tax, Audit & Accounting businesses. The company raised its full-year revenue outlook, citing stronger-than-expected first-half results and con
Via MarketBeat · August 5, 2026
TAT Technologies (NASDAQ:TATT) reported record second-quarter results for 2026 as improving supply-chain conditions helped the aviation aftermarket company convert previously constrained demand into revenue. Management said the company ended June with a record $650 million backlog and long-term agre
Via MarketBeat · August 5, 2026
Taboola.com (NASDAQ:TBLA) reported second-quarter results that exceeded its guidance for key profitability measures, despite revenue headwinds from a Google policy change and the company’s decision to remove lower-quality publishers from its network.
Revenue rose 2% year over year to $476.8 million
Via MarketBeat · August 5, 2026
SolarEdge Technologies (NASDAQ:SEDG) reported second-quarter results that marked a return to non-GAAP operating profitability, as higher revenue, improving margins and cost controls offset continued softness in the U.S. residential solar market.
Revenue for the quarter ended June 30 was $346.2 mill
Via MarketBeat · August 5, 2026
Skyward Specialty Insurance Group (NASDAQ:SKWD) reported higher second-quarter earnings and premium volume, supported by underwriting profitability, growth in several specialty businesses and increased investment income.
Chairman and Chief Executive Officer Andrew Robinson called the quarter “simpl
Via MarketBeat · August 5, 2026
SLR Investment (NASDAQ:SLRC) reported second-quarter 2026 net investment income of $0.33 per share and net income of $0.15 per share, as the business development company continued to emphasize specialty finance lending amid what executives described as a more challenging direct-lending environment.
Via MarketBeat · August 5, 2026
Recursion Pharmaceuticals (NASDAQ:RXRX) outlined progress across its clinical pipeline, drug-discovery partnerships and AI-enabled research platform, while lowering its 2026 cash operating expense guidance to $375 million and reaffirming expectations for an operating runway through early 2028.
The
Via MarketBeat · August 5, 2026
Royalty Pharma (NASDAQ:RPRX) raised its 2026 outlook for the second consecutive quarter after reporting higher second-quarter royalty receipts, continued capital deployment and progress across its development-stage pipeline.
Chief Executive Officer Pablo Legorreta said the company delivered 6% grow
Via MarketBeat · August 5, 2026
Gibraltar Industries (NASDAQ:ROCK) reported second-quarter 2026 results that included the first full quarter of operations from OmniMax International, while reiterating its full-year guidance. The company said residential and AgTech delivered organic growth, all segments posted sequential margin exp
Via MarketBeat · August 5, 2026
Ulta Beauty posted stronger-than-expected quarterly sales, earnings, and margins and raised its full-year guidance, though analysts remain cautious about cost pressures and competition.
Via MarketBeat · August 5, 2026
Palomar (NASDAQ:PLMR) reported record second-quarter adjusted net income and raised its full-year outlook for the third time in 2026, citing growth across its diversified specialty insurance portfolio, higher net earned premiums, underwriting discipline and stronger investment income.
Adjusted net
Via MarketBeat · August 5, 2026
Insulet (NASDAQ:PODD) reported second-quarter revenue growth of 23% on a constant-currency basis, supported by demand for its Omnipod insulin-delivery system in the U.S. and international markets, while raising its international outlook and reducing its U.S. and total-company revenue-growth expectat
Via MarketBeat · August 5, 2026
Commercial Metals (NYSE:CMC) used its 2026 Investor Day to outline a strategy centered on expanding its early-stage construction offerings, improving operating performance and generating higher cash flow and returns by fiscal 2029.
President and CEO Peter Matt said the company is evolving from a st
Via MarketBeat · August 5, 2026
BeOne Medicines (NASDAQ:ONC) reported second-quarter revenue of $1.7 billion, up 30% from a year earlier, and GAAP earnings per ADS of $2.05, up 144%, as sales of its BTK inhibitor BRUKINSA continued to expand across approved indications and global markets.
Chief Executive Officer John Oyler said t
Via MarketBeat · August 5, 2026